Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002

Author： Gerlich Miriam   Gschwend Patrick   Uchtenhagen Ambros   Krämer Alexander   Rehm Jürgen  

Publisher： Springer Publishing Company

ISSN： 0393-2990

Source： European Journal of Epidemiology, Vol.21, Iss.7, 2006-07, pp. : 545-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and treatment of HIV and hepatitis virus infections in Swiss correctional facilities

By Gerlich Miriam  

International Journal of Public Health, Vol. 53, Iss. 5, 2008-10 ,pp. : 268-271

Springer Publishing Company

Access to resources Recommend Favorite

Critical value of prevalence for vaccination programmes. The case of hepatitis A vaccination in Spain

By Rubio P.P.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1445-1450

Elsevier

Access to resources Recommend Favorite

The Economics of Hepatitis B Virus Vaccination: An Analysis of Cost-Effectiveness Results for Switzerland

By Zurn P.  

Disease Management & Health Outcomes, Vol. 7, Iss. 6, 2000-06 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite

Is there a causal link between hepatitis B vaccination and multiple sclerosis?

By Monteyne P.   Andre F.E.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 1994-2001

Elsevier

Access to resources Recommend Favorite

The information network of senior citizens in Geneva, Switzerland, and progress in flu vaccination coverage between 1991 and 2000

By Toscani L.   Gauthey L.   Robert C.-F.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 393-398

Elsevier

Access to resources Recommend Favorite